|
|
| March 25, 2012: Dr. Harry Roger Buller and Dr. Anjan K. Chakrabarti discuss: The EINSTEIN PE Study: Oral Rivaroxaban Alone for Symptomat |
Dr. Harry Roger Buller and Dr. Anjan K. Chakrabarti discuss: The EINSTEIN PE Study: Oral
Rivaroxaban Alone for Symptomatic Pulmonary Embolism.
Research Support/P.I., Consultant, Scientific Advisory Board: Sanofi-aventis, Bayer
HealthCare, Bristol-Myers Squibb, Daiichi-Sankyo, GlaxoSmithKline, Pfizer, Roche, Isis,
Thrombogenic
[ Download video ] |
|
No comments have been submitted
|